PrCa VBIR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PrCa VBIR, covering 2023-11-02 to 2023-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR) [Phase 1]